Left Brain Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,484
Closed -$3.39M 104
2026
Q1
$3.39M Buy
11,484
+91
+0.8% +$27K 1.33% 27
2025
Q4
$3.11M Buy
11,393
+13
+0.1% +$3.53K 1.08% 33
2025
Q3
$3.07M Sell
11,380
-153
-1% -$41.6K 0.97% 33
2025
Q2
$3.18M Buy
+11,533
New +$3.14M 1.12% 31
2024
Q4
Sell
-2,859
Closed -$631K 96
2024
Q3
$631K Sell
2,859
-170
-6% -$35.2K 0.29% 58
2024
Q2
$596K Sell
3,029
-95
-3% -$19.6K 0.28% 56
2024
Q1
$673K Sell
3,124
-45
-1% -$9.45K 0.33% 53
2023
Q4
$667K Buy
3,169
+20
+0.6% +$4.27K 0.39% 53
2023
Q3
$630K Buy
3,149
+67
+2% +$13.3K 0.39% 55
2023
Q2
$571K Buy
3,082
+135
+5% +$24.9K 0.35% 58
2023
Q1
$547K Buy
+2,947
New +$533K 0.37% 56

Other funds holding CME

Left Brain Wealth Management's CME Position: Q2 2026 in Review

Left Brain Wealth Management sold out of CME Group (CME) in Q2 2026, closing a stake of 11,484 shares — an estimated $3.39M sold.

Left Brain Wealth Management first reported a position in CME in Q1 2023 and held it in 11 quarters. The position peaked at $3.39M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Left Brain Wealth Management reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Left Brain Wealth Management sold 11,484 CME Group shares in Q2 2026, an estimated $3.39M.
  • Left Brain Wealth Management first reported a position in CME Group in Q1 2023 and held it in 11 quarters.
  • Left Brain Wealth Management's CME Group position peaked at $3.39M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Left Brain Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.